Novel anti-inflammatory drugs in hypertension
Open Access
- 23 January 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 21 (4) , 859-864
Abstract
‘Atherosclerosis is a chronic inflammatory disease induced by cholesterol …’Keywords
This publication has 77 references indexed in Scilit:
- Arterial Stiffness Is Related to Systemic Inflammation in Essential HypertensionHypertension, 2005
- Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention TrialNew England Journal of Medicine, 2005
- Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma PreventionNew England Journal of Medicine, 2005
- Selective COX-2 Inhibitors and Renal Injury in Salt-Sensitive HypertensionHypertension, 2005
- The Effects of Cyclooxygenase-2 Inhibitors and Nonsteroidal Anti-inflammatory Therapy on 24-Hour Blood Pressure in Patients With Hypertension, Osteoarthritis, and Type 2 Diabetes MellitusArchives of internal medicine (1960), 2005
- Endocannabinoids Acting at Cannabinoid-1 Receptors Regulate Cardiovascular Function in HypertensionCirculation, 2004
- Blood Pressure, C-Reactive Protein, and Risk of Future Cardiovascular EventsCirculation, 2003
- Short- and Long-Term COX-2 Inhibition Reverses Endothelial Dysfunction in Patients With HypertensionHypertension, 2003
- C-Reactive Protein, Carotid Intima-Media Thickness, and Incidence of Ischemic Stroke in the ElderlyCirculation, 2003
- Effects of celecoxib and rofecoxib on blood pressure and edema in patients ≥65 years of age with systemic hypertension and osteoarthritisThe American Journal of Cardiology, 2002